Avadel Pharmaceuticals (AVDL) News Today $8.18 +0.21 (+2.63%) Closing price 04:00 PM EasternExtended Trading$8.12 -0.05 (-0.67%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period SG Americas Securities LLC Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)SG Americas Securities LLC increased its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 274.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 46,767 shares of the company's stock after buying an additional 34,281 shares during the perFebruary 2 at 3:10 AM | marketbeat.comLeerink Partnrs Has Bullish Outlook for AVDL FY2027 EarningsFebruary 1 at 3:33 AM | americanbankingnews.comLeerink Partnrs Brokers Increase Earnings Estimates for AVDLAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Stock analysts at Leerink Partnrs lifted their FY2027 earnings estimates for Avadel Pharmaceuticals in a research report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now forecasts that the company will post earningsJanuary 31, 2025 | marketbeat.comWealth Effects LLC Acquires 110,359 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Wealth Effects LLC grew its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 4.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 2,344,130 shares of the company's stock after acquiring an additional 110,359 shares during the perioJanuary 28, 2025 | marketbeat.comJPMorgan Chase & Co. Decreases Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)JPMorgan Chase & Co. reduced its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 37.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,025 shares of the company's stock after selling 68,January 24, 2025 | marketbeat.comLinda Palczuk Acquires 5,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) StockJanuary 23, 2025 | insidertrades.comAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and ReimbursementJanuary 22, 2025 | finanznachrichten.deAvadel Pharmaceuticals director Linda Palczuk acquires $39,640 in sharesJanuary 22, 2025 | msn.comLinda Palczuk Purchases 5,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) StockAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) Director Linda Palczuk acquired 5,000 shares of the stock in a transaction dated Tuesday, January 21st. The stock was acquired at an average cost of $7.93 per share, for a total transaction of $39,650.00. Following the purchase, the director now directly owns 67,900 shares in the company, valued at approximately $538,447. The trade was a 7.95 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.January 22, 2025 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of "Buy" by AnalystsShares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) have received an average rating of "Buy" from the seven analysts that are currently covering the firm, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month price target among broJanuary 21, 2025 | marketbeat.comThere May Still Be Time to Get in on These 3 Trending BiotechsBiotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.January 20, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up After Insider Buying ActivityAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up Following Insider Buying ActivityJanuary 15, 2025 | marketbeat.comPeter J. Thornton Buys 10,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) StockJanuary 15, 2025 | insidertrades.comPeter J. Thornton Purchases 10,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) StockAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) Director Peter J. Thornton bought 10,000 shares of the firm's stock in a transaction on Monday, January 13th. The stock was acquired at an average cost of $8.04 per share, with a total value of $80,400.00. Following the completion of the purchase, the director now owns 104,055 shares of the company's stock, valued at approximately $836,602.20. This trade represents a 10.63 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.January 14, 2025 | marketbeat.comAvadel Pharmaceuticals price target lowered to $14 from $22 at UBSJanuary 14, 2025 | markets.businessinsider.comAvadel Pharmaceuticals (NASDAQ:AVDL) Given New $14.00 Price Target at UBS GroupUBS Group dropped their target price on shares of Avadel Pharmaceuticals from $22.00 to $14.00 and set a "buy" rating on the stock in a report on Monday.January 13, 2025 | marketbeat.com3 Oversold Biotech NamesJanuary 13, 2025 | seekingalpha.comWhat is Lifesci Capital's Forecast for AVDL FY2024 Earnings?Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Equities researchers at Lifesci Capital reduced their FY2024 earnings per share estimates for shares of Avadel Pharmaceuticals in a research note issued on Thursday, January 9th. Lifesci Capital analyst M. Belghiti now forecasts that the coJanuary 13, 2025 | marketbeat.comAvadel Pharmaceuticals: Patient Attrition Weighs On 2025 OutlookJanuary 12, 2025 | seekingalpha.comUBS cuts Avadel target, says shares ‘significantly cheap’January 11, 2025 | markets.businessinsider.comOppenheimer cuts Avadel target, would buy on weaknessJanuary 10, 2025 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL) and ProQR (PRQR)January 10, 2025 | markets.businessinsider.comPiper Sandler Lowers Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target to $13.00Piper Sandler cut their price objective on shares of Avadel Pharmaceuticals from $24.00 to $13.00 and set an "overweight" rating on the stock in a report on Friday.January 10, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Sets New 12-Month Low Following Analyst DowngradeAvadel Pharmaceuticals (NASDAQ:AVDL) Sets New 1-Year Low After Analyst DowngradeJanuary 10, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Earns Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and issued a $21.00 target price (down from $25.00) on shares of Avadel Pharmaceuticals in a research report on Friday.January 10, 2025 | marketbeat.comAvadel Pharmaceuticals price target lowered to $19 from $22 at NeedhamJanuary 10, 2025 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Avadel Pharmaceuticals (AVDL) and ACADIA Pharmaceuticals (ACAD)January 9, 2025 | markets.businessinsider.comNeedham & Company LLC Has Lowered Expectations for Avadel Pharmaceuticals (NASDAQ:AVDL) Stock PriceNeedham & Company LLC dropped their price target on Avadel Pharmaceuticals from $22.00 to $19.00 and set a "buy" rating on the stock in a research note on Thursday.January 9, 2025 | marketbeat.comAvadel Pharmaceuticals plc: Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ LaunchJanuary 9, 2025 | finanznachrichten.deAvadel Pharmaceuticals plc: Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)January 9, 2025 | finanznachrichten.deAvadel Pharmaceuticals sees FY24 revenue $169M, consensus $171.41MJanuary 9, 2025 | markets.businessinsider.comAvadel Sees Narcolepsy Drug Fueling Earnings GrowthJanuary 8, 2025 | marketwatch.comAvadel Shares Sink After Revenue Forecast Misses Wall Street EstimatesJanuary 8, 2025 | marketwatch.comAvadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ LaunchJanuary 8, 2025 | globenewswire.comAvadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To ExpectJanuary 7, 2025 | finance.yahoo.comAvadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)January 6, 2025 | globenewswire.comAvadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8January 3, 2025 | globenewswire.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Purchased by State Street CorpState Street Corp increased its position in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 42.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,623,302 shares of the company's stock after buying an additiDecember 24, 2024 | marketbeat.comBarclays PLC Has $5.15 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Barclays PLC boosted its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 45.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 392,691 shares of the company's stock after acquirDecember 21, 2024 | marketbeat.comAvadel Pharmaceuticals PLC AVDLDecember 20, 2024 | morningstar.comLeerink Partners Remains a Buy on Avadel Pharmaceuticals (AVDL)December 18, 2024 | markets.businessinsider.comInsider Buying: Avadel Pharmaceuticals plc (NASDAQ:AVDL) CFO Purchases 2,300 Shares of StockDecember 17, 2024 | insidertrades.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Position Boosted by Lord Abbett & CO. LLCLord Abbett & CO. LLC grew its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 23.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 489,073 shares of the company's stock after purchasing an additiDecember 17, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) CFO Thomas S. Mchugh Purchases 2,300 SharesAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) CFO Thomas S. Mchugh bought 2,300 shares of Avadel Pharmaceuticals stock in a transaction dated Friday, December 13th. The stock was purchased at an average cost of $10.44 per share, for a total transaction of $24,012.00. Following the completion of the acquisition, the chief financial officer now directly owns 87,800 shares of the company's stock, valued at approximately $916,632. The trade was a 2.69 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.December 16, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Up 11.1% in NovemberAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the recipient of a significant growth in short interest in November. As of November 30th, there was short interest totalling 9,790,000 shares, a growth of 11.1% from the November 15th total of 8,810,000 shares. Based on an average daily volume of 1,180,000 shares, the days-to-cover ratio is currently 8.3 days.December 15, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) CFO Thomas S. Mchugh Purchases 5,000 SharesDecember 13, 2024 | insidertrades.com48,961 Shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Acquired by XTX Topco LtdXTX Topco Ltd bought a new position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 48,961 shares of the company's stock, valued at approximately $642,000. XTX Topco Ltd ownedDecember 13, 2024 | marketbeat.comIndependent Non-Executive Chairman of the Board of Avadel Pharmaceuticals Picks Up 16% More StockDecember 12, 2024 | finance.yahoo.comAvadel Pharmaceuticals announces publication of findings on sodium oxybateDecember 11, 2024 | markets.businessinsider.comResults from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate TherapyDecember 11, 2024 | finance.yahoo.com Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address AVDL Media Mentions By Week AVDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼1.150.44▲Average Medical News Sentiment AVDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼64▲AVDL Articles Average Week Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACAD News Today XENE News Today ZLAB News Today VCEL News Today MOR News Today RXRX News Today MLTX News Today MRUS News Today CPRX News Today SWTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 2/4/2025 by MarketBeat.com Staff From Our PartnersBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredJUST RELEASED: HUGE NEW A.I. TRADEI’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avadel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
